Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, Africa, Agency, America, Amgen, Biotechnology, capacity, commitment, Consumer, customer, denosumab, dollar, Eli, Enbrel, Exhibit, fee, flat, footnote, forgo, Genentech, guaranteed, Herceptin, Humira, immaterial, Immunex, inclusion, independent, institutional, italicized, Janssen, Latin, leg, mandatory, maximum, mechanism, mutual, NQSO, objectively, Policy, Prolia, qualified, recoupment, refinanced, refinancing, registered, Remicade, removed, repay, revised, RSU, spending, spread, Street, swap, text, tranche, unsecured, Wall, Xgeva, Zenhale
Filing tables
Filing exhibits
Related press release
Associated OGN transcripts
OGN similar filings
Filing view
External links